drugset / Trial / NCT00826852
Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is: * to assess the efficacy of the combination in terms of Objective (clinical and radiological) Response Rate * to assess the time to progression of the disease; assess the safety profile of the combination, and assess the survival time.
Timeline
- Start
- 2003-10
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | — |